Figure 7
From: Potential carriers of chemotherapeutic drugs: matrix based nanoparticulate polymeric systems
The relative tumour uptake of PETRA crosslinked PEGDA formulation (PP1) compared to the contralateral normal muscle (tumour:muscle ratio) over a period of 24 h.